Clinical trial
The Effect of Rifampin on Etonogestrel Concentrations in Contraceptive Implant Users
NCT04463680 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Rifampin on Etonogestrel Concentrations in Contraceptive Implant Users
- Lead sponsor
- University of Colorado, Denver
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- September 23, 2020
- Completion date
- February 22, 2022
- Enrollment
- 24 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
contraception, tuberculosis